FADS1 serves as a candidate shared biomarker for metabolic dysfunction-associated steatohepatitis related early-onset colorectal cancer identified via machine learning and in vitro validation
Source check: Source checked. Not independent scientific confirmation.
Finding: ML nominates FADS1 as a candidate shared biomarker in MASH-associated early-onset colorectal cancer, with public-cohort analyses and limited laboratory assays. Authors describe associations and acknowledge no direct genetic perturbation; the result is exploratory.
Technology: glmBoost and XGBoost selected from 44 evaluated machine-learning configurations
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- PDF Methods/Results: 44 algorithm configurations select glmBoost+XGBoost; external cohorts, single-cell virtual knockout, cell-line qPCR/WB, and small IHC sets (4 EO-CRC, 4 LO-CRC). Authors note no direct perturbation and association-only mechanism.
- Test and result
- PDF Methods/Results: 44 algorithm configurations select glmBoost+XGBoost; external cohorts, single-cell virtual knockout, cell-line qPCR/WB, and small IHC sets (4 EO-CRC, 4 LO-CRC). Authors note no direct perturbation and association-only mechanism.
- Limitation / still unknown
- PDF Methods/Results: 44 algorithm configurations select glmBoost+XGBoost; external cohorts, single-cell virtual knockout, cell-line qPCR/WB, and small IHC sets (4 EO-CRC, 4 LO-CRC). Authors note no direct perturbation and association-only mechanism.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1007/s12672-026-06235-y
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.